五十嵐敦之
論文、出版物等
1）Hidehisa S，et al．English version of guidelines for the management of asteatosis 2021 in Japan．J Dermatol．49(3)，2022，e77-e90．（PMID：34970776）
2）Shunsuke I，et al．Immune-related dermatitis during combined treatment with pembrolizumab and axitinib in a patient with metastatic renal cellx92carcinoma with stasis dermatitis．IJU Case Rep．4(6)，2021，386-390．（PMID：34755064）
3）Hidemi N，et al．Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study．J Am Acad Dermatol．85(4)，2021，854-862．（PMID：34118298）
4）Timo B，et al．Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies．Dermatol Ther (Heidelb)．11(3)，2021，971-982．（PMID：33899152）
5）Atsuyuki I，et al．Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1)．J Dermatol．48(6)，2021，853-863．（PMID：33630387）
6）Shinichi I，et al．Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1)．J Dermatol，48(6)2021，844-852．（PMID：33523513）
7）五十嵐敦之編．皮膚疾患全身療法薬 up-to-date．南江堂．2020．（ISBN：9784524249435）
看護roo!での執筆・監修
- 看護知識
- 執筆
執筆記事
看護知識
